The read at a glance
Computed from the FY2025 annual filing. Full history and the components behind each score are in the app.
- Distress risk · Altman Z-Score 1.97 — grey zone — between safe and distressedWatch
- Earnings-manipulation signal · Beneish M -3.13 — no flag raisedOK
- Earnings quality 61/100 — worth a closer lookWatch
Where the revenue comes from
Fiscal 2025, as RxSight, Inc. reports it. History and quarterly detail are in the app.
- Rxlal$108.1M
- LDD$20.7M
- Service Warranty Service Contracts And Accessories$5.7M
Leadership changes
From RxSight, Inc.'s own filings, the day they're filed.
- Eric Weinberg · Chief Commercial Officer · appointmenteff. 2025-12-18
- Scott Gaines · Chief Customer Officer · appointmenteff. 2025-12-18
- Raymond W. Cohen · director · appointmenteff. 2025-07-31
Latest filings
- 8-K · Company announcement2026-08-05
- 10-Q · Quarterly report2026-08-05
- 8-K · Company announcement2026-07-15
- 8-K · Company announcement2026-07-06
- 8-K · Company announcement2026-07-06
In the full recordFree for 14 days
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about RxSight, Inc., every answer cited to the official filings🔒
- The Intelligence Brief — added when RxSight, Inc.'s brief passes our SEC-figure check🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.